Browsing by Author Bell, Richard (Prof)

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
20072-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.Wilcken, Nicholas; Baselga, Jose (Prof); Bell, Richard (Prof); Bergh, Jonas (Prof); Cameron, David; Coleman, Robert; Dowsett, Mitch (Prof); Feyereislova, Andrea; Gelber, Richard D. (Prof); Gelmon, Karen (Prof); Goldhirsch, Aron (Prof); Guillaume, Sebastien; Harbeck, Nadia; Kaufmann, Manfred (Prof); Lopez, Roberto I; Mallmann, Peter (Prof); Mariani, Gabriella; Piccart-Gebhart, Martine J (Prof); Procter, Marion; Sanchez Rovira, Pedro; Smith, Ian (Prof); Untch, Michael (Prof); Wardley, Andrew; Wist, Erik (Prof); Western Clinical School: Medicine (Westmead)2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial., The Lancet, vol.369,(9555),2007,pp 29-36
2010Establishment of the Australian In Situ Hybridization Program for the Assessment of HER2 Amplification in Breast Cancer: A Model for the Introduction of New Biomarkers Into Clinical PracticeBilous, Michael; Armes, Jane; Bell, Richard (Prof); Cummings, Margaret; Farshid, G; Fox, Stephen B.; Francis, Glenn; Haswell, Martin; McCue, Glenda; Morey, Adrienne; Raymond, W.; Robbins, Peter; Western Clinical School: Medicine (Westmead)Establishment of the Australian In Situ Hybridization Program for the Assessment of HER2 Amplification in Breast Cancer: A Model for the Introduction of New Biomarkers Into Clinical Practice, Diagnostic Molecular Pathology, vol.19, 4,pp 187-193
2013Prevention of aromatase inhibitor-induced bone loss with alendronate in postmenopausal women: The BATMAN trialSambrook, Philip; Abdi, Ehtesham; Beith, Jane M.; Bell, Richard (Prof); Broad, A; Henry, Margaret; Lee, Chooi; Lomax, Anna; Pocock, Nicholas; Sewak, Sanjeev; White, Karen; Yap, Saw Yee; Yeow, Elaine; Northern Clinical School: MedicinePrevention of aromatase inhibitor-induced bone loss with alendronate in postmenopausal women: The BATMAN trial, Journal of Bone Oncology, vol.2, 4, 2013,pp 145-153